Research Training Opportunities & News | |
The CPH Office of Research is excited to host Jessica Koenigsknecht-Talboo, PhD., Director of Foundation and Corporate Philanthropy and Hannah O’Leary, MPA, Associate Director of Foundation and Corporate Philanthropy who will present on foundation and corporate funding opportunities, the databases UK has invested in and how the office of philanthropy can assist with proposals. | |
Navigating the IRB Recording Available! | |
Unable to attend the Office of Scientific Writing presentation on
Navigating the IRB? Click on the Research YouTube Channel Video above.
Resources
| |
Vice President for Research Lunch & Learn | |
February 2, 2022 at 12PM
Zoom: https://uky.zoom.us/j/9251686420
Phone: 646-876-9923 Meeting ID: 925 168 6420
UK Research Leadership Academy: Further Advancement of UK’s Research Culture
Speakers:
- Linda Dwoskin (Senior Associate Vice President for Research)
- Lisa Cassis (Vice President for Research)
- Kathy Grzech (Executive Director, Proposal Development Office)
February 16, 2022 at 12PM
Zoom: https://uky.zoom.us/j/9251686420
Phone: 646-876-9923 Meeting ID: 925 168 6420
Just Get Rid of It? The Importance of Data Annotation and Storage
Speakers:
- Helene Lake-Bullock (Assistant Vice President for Research, Director, Office of Research Integrity)
- Alan Daugherty (Associate Vice President for Research)
| |
CCTS Conference & College of Public Health Research Day | |
The mission of the CHET Just-in-Time (JIT) grant mechanism is to enable health equity researchers to obtain small funding amounts to support competitive extramural grant applications, manuscripts submission fees, conference registrations, or support critical health equity training (directly related to an health equity research project). This small grants program is designed to support CHET members and affiliates in conducting health equity related work.
Eligibility is limited to full-time faculty (all title series including regular, research, clinical and special) and post-doctoral fellows at the University of Kentucky who are CHET affiliates or CHET core faculty (to request CHET affiliation please email ariel.arthur@uky.edu). The JIT grants are open to health equity studies affecting any vulnerable group or population affected by health disparities.
Eligible investigators may apply for up to $2000 annually from CHET. If you have received pilot or other award funding from CHET in the fiscal year, you will not be eligible for CHET JIT funding. The Just-in-Time funding must be spent within the fiscal year awarded. Awards are made on a rolling basis and will continue until funds have been expended. $10,000 will be available for JIT funding for this fiscal year.
Submissions accepted Spring 2022: January 1, 2022 – April 30, 2022 until funds are expended
| |
The UK Center for Clinical and Translational Science (CCTS) is now accepting applications for collaborative pilot projects.
The purpose of this funding mechanism is to provide a new opportunity and resources to support innovative, collaborative research relevant to the health challenges and disparities faced by the nation and the citizens of Kentucky. The funding for these pilot studies is derived from the CCTS program in partnership with other UK Centers, and with other Universities in the Appalachian Translational Research Network (ATRN). This award will give priority to studies with a disease focus or with collaboration between UK and other Universities.
Participating institutions:
- UK
- Wake Forest University
Participating UK Centers:
- Barnstable Brown Diabetes Center
- Markey Cancer Center
- Sanders Brown Center on Aging
- Spinal Cord and Brain Injury Research Center
Letters of Intent Due February 13, 2022
| |
CCTS Collaborative Pilot Awards 2022 Call for Applications | |
The UK Center for Clinical and Translational Science (CCTS) is now accepting applications for Pilot Projects. The purpose of this funding mechanism is to provide a new opportunity and resources to support innovative, collaborative research relevant to the health challenges and disparities faced by the nation and the citizens of Kentucky. Within the general guidelines outlined below, the types of projects that will be considered within these mechanisms include projects that:
- Provide support for early career investigators.
- Stimulate the development of new clinical and translational inter- and multidisciplinary teams.
- Promote community-based research.
- Develop new methodologies to leverage institutional strengths and new initiatives.
- Pursue high-risk, high reward studies.
The following categories of awards are open to UK full-time faculty members. Funding for these awards will include contributions from other UK Centers; therefore applications are encouraged with the following focus:
Cancer: One award of up to $50,000, in total direct cost, will be made available to support meritorious projects that address cancer control, prevention, and/or community engagement topics that focus on the high incidence of cancer in Appalachia Kentucky. Potential studies could focus on psychosocial, behavioral, health policy, health services, cancer health equity, and other areas addressing cancer disparities in Appalachia Kentucky. Award duration is 12 months.
Diabetes and Obesity: One award of up to $50,000, in total direct cost, will be made available to support meritorious projects that address basic and clinical translational aspects of diabetes and/or obesity. Award duration is 12 months.
Spinal Cord and Brain Injury Research: One award of up to $50,000, in total direct cost, will be made available to support a meritorious project that address basic and clinical translational aspects of injuries to the spinal cord and brain that result in paralysis or other loss of neurologic function. Award duration is 12 months.
Alzheimer’s and Neurodegenerative diseases: One award of up to $25,000, in total direct cost, will be given to a meritorious project that focuses on innovative basic, translational and clinical studies relevant to aging and/or Alzheimer’s disease (AD). Award duration is 12 months.
- Basic science proposals with a focus on translational research relevant to AD are strongly encouraged and of particular interest.
- Clinical proposals that investigate risk factors, prevention, preclinical AD, caregiving, minority populations, vascular cognitive impairment, cognitive processes, and neuroimaging are also encouraged.
For questions regarding these funding opportunities, contact: Joel Thompson, PhD, CCTS Research Development Director & Pilot Funding Project Manager, at Joel.Thompson@uky.edu
| |
UK UNITE RESEARCH PRIORITY AREA
Community Engagement RFA
| |
The United in True Racial Equity (UNITE) Research Priority Area (RPA) mission is to support research focused on social and racial justice, racial disparities, and racial health equity that will result in impactful scholarly outputs and extramural funding for sustainability. The UNITE RPA facilitated a community-led discussion on April 15, 2021 designed to advance this objective by connecting university researchers with communities of color across the Commonwealth (areas included: Louisville Metro, Lexington, Owensboro) and allowing their lived experiences to inform impactful research priorities. Please review the summary of the discussion.
Community leaders identified several key priority areas critical to the wellbeing of their communities such as: adequate food, housing, healthcare, and education. Further, UK researchers were challenged to address the needs of marginalized communities by amplifying the voices and validating the lived experiences of community members through research to elevate evidence-based advocacy. Ultimately, the panelists recommended an intergenerational, intersectional, intercultural approach to research projects, as opposed to allowing data findings to undermine the lived experiences of community members.
This notice solicits applications for pilot projects that will utilize theory-driven, evidence-based, and culturally appropriate strategies to address critical needs identified within communities of color.
Projects that are responsive will:
- address one or more of the identified key priority areas (above);
- involve an active partnership with one or more community leaders or community-based organizations; and
- be designed with plans for next steps to seek extramural funding and scale-up the project.
| |
UK UNITE/College of Social Work RFA |
The UNITE RPA and College of Social Work are excited to release a collaborative pilot funding opportunity to support projects that will utilize an RCT (randomized clinical trial) design and increase underrepresented racial/ethnic scholars in research.
Eligibility is limited to full time faculty at UK who are members of the UNITE Research Priority Area. If you are interested in applying and are not a member of UNITE RPA please email UNITE-RPA@uky.edu.
A maximum of $50,000 will be awarded for a period of 18 months. Applications are due March 31, 2022.
| |
Community Level Interventions to Improve Minority Health and Reduce Health Disparities
(R01 Clinical Trial Optional)
|
Agency: NIH, National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Mental Health (NIMH)
Description: This initiative will support research projects to develop and test prospective community-level interventions to improve minority health and decrease health disparities. Community-level intervention projects are expected to have the following features:
- Are led by or conducted in collaboration and full partnership with appropriate community partners, such as community-based organizations, faith-based organizations, local businesses, neighborhood associations, labor unions, patient or consumer advocacy groups, public health departments, healthcare systems, school systems, law enforcement or criminal justice agencies, social service agencies, or departments of commerce, labor, transportation, housing, recreation. Multi-sectoral collaborations involving partnerships with multiple types of organizations in the public and private sector are strongly encouraged.
- Are focused on improving health outcomes or reducing health disparities in one or more NIH-designated health disparity populations in the US.
- Are focused on the entire population in communities (e.g., an intervention to increase the availability of fresh produce or walkable green spaces) or a specific population within communities (e.g., an intervention to improve physical activity among high school students or older adults within the community).
- Are guided by a conceptual model identifying hypothesized pathways between the community-level intervention, community-level determinants, and health outcomes.
- Collect or obtain data beyond individual self-report to determine how the intervention is impacting community-level determinants of health.
- Are supported by relevant preliminary data. It is not required for the community-level intervention to have been pilot tested in multiple communities.
- Prospectively test the impact of interventions on self-reported or measured health outcomes. Retrospective analysis of existing or past community-level interventions or initiatives are not responsive to this initiative.
- Include health outcomes at the individual, interpersonal/organizational, or community level, or a combination.
- Use appropriate measures and analytic methods appropriate for examining community-level mechanisms of action and health outcomes.
- Test interventions that have the potential to be sustainable in the community after project funding is over.
Announcement Number: RFA-MD-22-007
Closing Date: March 8, 2022
| |
HRSA – Health Workforce Research Center Cooperative Agreement Program, (U81) –
HRSA-22-054
| |
Purpose: The purpose of the Health Resources and Services Administration (HRSA) 2022 Health Workforce Research Center (HWRC) Cooperative Agreement Program is to support and disseminate rigorous research that strengthens evidence-based policy and enhances understanding of issues and trends in the health workforce. HRSA anticipates that up to nine (9) HWRC cooperative agreements will be funded under this notice. One HWRC focusing on the Public Health Workforce will be funded jointly by the Centers for Diseases Control and Prevention (CDC). One HWRC focusing on the Behavioral Health Workforce will be solely funded by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Funding Amount/ Project Period: Behavioral Health Workforce, up to $900,000 per year for 5 years; Public Health Workforce, up to $900,000 per year for 5 years; all others, up to $450,000 per year for 5 years
Internal Competition: To participate in the university’s selection process, please upload the following, assembled into a single PDF file, to the Office of the Vice President for Research via this portal with a copy to your Associate Dean for Research by February 22, 2022:
Names and departments or affiliations of the Project Director and other key personnel or partners;
- Title of program and/or funding opportunity announcement number;
- Brief project description (2 pages maximum)
- Brief biographical sketch
A committee will be convened to review the material and make a recommendation.
For questions or issues with submission through the portal, email the limited submission mailbox (limitedsubmissions@uky.edu), or call 257-2861.
Agency Deadline: April 14, 2022
| |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) | |
Agency: NIH
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription, and other substances) and related disorders, prevention of substance use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV. Primary data collection is not allowed for applications in response to this FOA.
Activity Code: R01
Announcement Number: RFA-DA-22-037
Closing Date: March 4, 2022
| | | | |